Search
for
Sort by
Research 31–60 of 1000+
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?
- The natural history of androgenetic alopecia
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- 5α-Reductase Inhibitors – The Finasteride Story
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience
- Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats
- Introduction to: Endocrinological aspects of andrology—what is new?
- 9 Role of 5α-reductase in health and disease
- A New Look at the 5?-Reductase Inhibitor Finasteride
- Finasteride for prostatic disease: an updated and comprehensive review
- Structure of human type II 5 alpha-reductase gene
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Does a male polycystic ovarian syndrome equivalent exist?
- Novel inhibitors of 5α-reductase
- Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone.
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Keyora Integrated Nutritional Modulation of the Redox–NO–Androgen Axis in Male Endocrine, Reproductive, and Metabolic Disorders
- Melasma and Endocrine Disorders
- Risk of New-Onset Postoperative Depression After Holmium Laser Enucleation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Nationwide Retrospective Cohort Study
- Androgenic alopecia and its association with metabolic syndrome
- 5-Alpha reductase deficiency